Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influvac 2006/2007 immunogenicity study in healthy adults and elderly subjects
2006-001300-37Phase 3Completed
- Sponsor
- Solvay Pharmaceuticals
- Start
- Apr 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, open-label trial of influenza vaccine in influenza (2 arms), sponsored by Solvay Pharmaceuticals. Primary endpoint: Serological parameters derived from observed hemagglutination inhibition titers. Started Apr 2006; status: completed.
02
Drugs
influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on 2006-001300-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001300-37.